Wright Medical completed its previously announced acquisition of Cartiva, developer of the PMA-approved Synthetic Cartilage Implant to treat arthritis at the base of the great toe.
As noted in mid-3Q18, total price for the transaction was US $435MM in cash. Wright will provide updated full-year 2018 guidance, including the impact of this purchase, in its 3Q18 earnings call on November 7.
Wright Medical completed its previously announced acquisition of Cartiva, developer of the PMA-approved Synthetic Cartilage Implant to treat arthritis at the base of the great toe.
As noted in mid-3Q18, total price for the transaction was US $435MM in cash. Wright will provide updated full-year 2018 guidance,...
Wright Medical completed its previously announced acquisition of Cartiva, developer of the PMA-approved Synthetic Cartilage Implant to treat arthritis at the base of the great toe.
As noted in mid-3Q18, total price for the transaction was US $435MM in cash. Wright will provide updated full-year 2018 guidance, including the impact of this purchase, in its 3Q18 earnings call on November 7.
Copy to clipboard 
